Show simple item record

dc.contributor.authorUlirsch, Jacob C.
dc.contributor.authorNewburger, Peter E.
dc.contributor.authorKorostelev, Andrei A.
dc.contributor.authorSankaran, Vijay G.
dc.contributor.authorGazda, Hanna T.
dc.date2022-08-11T08:10:13.000
dc.date.accessioned2022-08-23T16:59:54Z
dc.date.available2022-08-23T16:59:54Z
dc.date.issued2018-12-06
dc.date.submitted2019-08-30
dc.identifier.citation<p>Am J Hum Genet. 2018 Dec 6;103(6):930-947. doi: 10.1016/j.ajhg.2018.10.027. Epub 2018 Nov 29. <a href="https://doi.org/10.1016/j.ajhg.2018.10.027">Link to article on publisher's site</a></p>
dc.identifier.issn0002-9297 (Linking)
dc.identifier.doi10.1016/j.ajhg.2018.10.027
dc.identifier.pmid30503522
dc.identifier.urihttp://hdl.handle.net/20.500.14038/43690
dc.description<p>Full author list omitted for brevity. For the full list of authors, see article.</p>
dc.description.abstractDiamond-Blackfan anemia (DBA) is a rare bone marrow failure disorder that affects 7 out of 1,000,000 live births and has been associated with mutations in components of the ribosome. In order to characterize the genetic landscape of this heterogeneous disorder, we recruited a cohort of 472 individuals with a clinical diagnosis of DBA and performed whole-exome sequencing (WES). We identified relevant rare and predicted damaging mutations for 78% of individuals. The majority of mutations were singletons, absent from population databases, predicted to cause loss of function, and located in 1 of 19 previously reported ribosomal protein (RP)-encoding genes. Using exon coverage estimates, we identified and validated 31 deletions in RP genes. We also observed an enrichment for extended splice site mutations and validated their diverse effects using RNA sequencing in cell lines obtained from individuals with DBA. Leveraging the size of our cohort, we observed robust genotype-phenotype associations with congenital abnormalities and treatment outcomes. We further identified rare mutations in seven previously unreported RP genes that may cause DBA, as well as several distinct disorders that appear to phenocopy DBA, including nine individuals with biallelic CECR1 mutations that result in deficiency of ADA2. However, no new genes were identified at exome-wide significance, suggesting that there are no unidentified genes containing mutations readily identified by WES that explain > 5% of DBA-affected case subjects. Overall, this report should inform not only clinical practice for DBA-affected individuals, but also the design and analysis of rare variant studies for heterogeneous Mendelian disorders.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=30503522&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288280/
dc.subjectDiamond-Blackfan anemia
dc.subjectRNA sequencing
dc.subjectcongenital hypoplastic anemia
dc.subjecthematopoiesis
dc.subjecthuman genetics
dc.subjectrare disease
dc.subjectwhole-exome sequencing
dc.subjectCongenital, Hereditary, and Neonatal Diseases and Abnormalities
dc.subjectGenetic Phenomena
dc.subjectGenetics and Genomics
dc.subjectHematology
dc.subjectHemic and Immune Systems
dc.subjectHemic and Lymphatic Diseases
dc.subjectMedical Genetics
dc.subjectNucleic Acids, Nucleotides, and Nucleosides
dc.subjectPediatrics
dc.titleThe Genetic Landscape of Diamond-Blackfan Anemia
dc.typeJournal Article
dc.source.journaltitleAmerican journal of human genetics
dc.source.volume103
dc.source.issue6
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/peds_pp/272
dc.identifier.contextkey15236969
html.description.abstract<p>Diamond-Blackfan anemia (DBA) is a rare bone marrow failure disorder that affects 7 out of 1,000,000 live births and has been associated with mutations in components of the ribosome. In order to characterize the genetic landscape of this heterogeneous disorder, we recruited a cohort of 472 individuals with a clinical diagnosis of DBA and performed whole-exome sequencing (WES). We identified relevant rare and predicted damaging mutations for 78% of individuals. The majority of mutations were singletons, absent from population databases, predicted to cause loss of function, and located in 1 of 19 previously reported ribosomal protein (RP)-encoding genes. Using exon coverage estimates, we identified and validated 31 deletions in RP genes. We also observed an enrichment for extended splice site mutations and validated their diverse effects using RNA sequencing in cell lines obtained from individuals with DBA. Leveraging the size of our cohort, we observed robust genotype-phenotype associations with congenital abnormalities and treatment outcomes. We further identified rare mutations in seven previously unreported RP genes that may cause DBA, as well as several distinct disorders that appear to phenocopy DBA, including nine individuals with biallelic CECR1 mutations that result in deficiency of ADA2. However, no new genes were identified at exome-wide significance, suggesting that there are no unidentified genes containing mutations readily identified by WES that explain > 5% of DBA-affected case subjects. Overall, this report should inform not only clinical practice for DBA-affected individuals, but also the design and analysis of rare variant studies for heterogeneous Mendelian disorders.</p>
dc.identifier.submissionpathpeds_pp/272
dc.contributor.departmentDepartment of Biochemistry and Molecular Pharmacology
dc.contributor.departmentRNA Therapeutics Institute
dc.contributor.departmentDepartment of Pediatrics
dc.source.pages930-947


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record